Director/PDMR Shareholding

GlaxoSmithKline PLC 20 July 2005 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons I give below details of changes in the interests of Directors, Persons Discharging Managerial Responsibility or Connected Persons in the Ordinary Shares of GlaxoSmithKline plc. 04 July 2005 The Administrators of the SmithKline Beecham Employee Benefit Trust ("the Trust") notified the Company on 19 July 2005 that 13,446 Ordinary shares had been transferred from the Trust to a participant in the GlaxoSmithKline Annual Investment Plan. The Trust also notified the Company on 19 July 2005 that following reinvestment of the cash dividend paid to shareholders on 07 July 2005, 707 Ordinary Shares in the Company had been purchased for participants in the SmithKline Beecham Bonus Investment Plan at a price of £13.73 per share. 15 July 2005 The Trust also notified the Company on 19 July 2005 that following reinvestment of the cash dividend paid to shareholders on 07 July 2005, 7,751 Ordinary Shares in the Company had been purchased for participants in the GlaxoSmithKline Annual Investment Plan at a price of £13.73 per share. 15 July 2005 The Trust is a discretionary fund of which all non US employees or former employees of GlaxoSmithKline plc and its subsidiaries are potential beneficiaries. One of the Company's directors, Julian Heslop is therefore interested in the shares held in the fund from time to time in the same way as other non US employees or former employees of GlaxoSmithKline plc and its subsidiaries. This notification relates to a transaction notified in accordance with Disclosure rule 3.1.4R(1)(b). S M Bicknell Company Secretary 20 July 2005 This information is provided by RNS The company news service from the London Stock Exchange

Companies

GSK (GSK)
UK 100

Latest directors dealings